ArticleTherapeutic advances in medical oncology2022

Expression of p53 as a biomarker of pazopanib efficacy in solitary fibrous tumours: translational analysis of a phase II trial.

Andrea Napolitano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.